Altimmune, Inc. (FRA:3G0)

Altimmune Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	442	495	547	756	319	341
Market Cap Growth	-30.89%	-9.42%	-27.71%	136.90%	-6.33%	1248.07%
Enterprise Value	275	362	420	569	145	173
Last Close Price	4.30	7.38	10.75	14.79	7.51	9.42
PS Ratio	25958.80	25640.43	1418.90	-11888.90	82.35	50.95
PB Ratio	2.80	4.15	3.11	4.36	1.82	1.85
P/TBV Ratio	2.80	4.15	3.11	4.68	1.95	1.96
EV/Sales Ratio	-	18760.08	1090.28	-	37.39	25.91
Debt / Equity Ratio	0.09	0.01	0.00	0.01	0.01	0.01
Asset Turnover	0	0	0.00	-	0.02	0.06
Quick Ratio	16.83	12.90	16.69	10.99	10.73	18.99
Current Ratio	17.18	13.11	17.26	11.31	11.17	19.16
Return on Equity (ROE)	-52.62%	-59.86%	-46.63%	-44.07%	-45.69%	-36.14%
Return on Assets (ROA)	-30.87%	-36.85%	-25.00%	-25.73%	-22.86%	-16.10%
Return on Capital (ROIC)	-33.59%	-40.31%	-27.38%	-28.31%	-24.76%	-17.52%
Return on Capital Employed (ROCE)	-43.90%	-80.10%	-42.10%	-46.20%	-42.30%	-16.50%
Earnings Yield	-16.16%	-18.54%	-14.63%	-10.48%	-26.74%	-11.76%
FCF Yield	-12.78%	-15.57%	-12.55%	-7.76%	-24.88%	-8.28%
Buyback Yield / Dilution	-17.16%	-33.35%	-13.47%	-13.67%	-61.03%	-95.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.